Page 1

✓ SABRA NEWS RELEASE Sabra Reports Second Quarter 2021 Results ; Announces Intent to Exit Its Enlivant Joint Venture Investment ; Provides Business Update and 2021 Guidance 2021-08-04 IRVINE , Calif .-- ( BUSINESS WIRE ) -- Sabra Health Care REIT , Inc. ( " Sabra , " the " Company " or " we " ) ( Nasdaq : SBRA ) today announced results of operations for the second quarter of 2021. In addition , the Company announced its intention to exit from the Enlivant Joint Venture , provided a business update and provided guidance for the full year 2021 . SECOND QUARTER 2021 RESULTS AND RECENT EVENTS Following are the highlights of our results for the second quarter of 2021 and recent events : For the second quarter of 2021 , net loss , FFO , Normalized FFO , AFFO and Normalized AFFO per diluted common share were $ ( 0.61 ) , $ 0.39 , $ 0.41 , $ 0.39 and $ 0.40 , respectively . Included in the net loss per diluted common share is a $ ( 0.76 ) impairment charge to our investment in unconsolidated joint venture . See further discussion under " Enlivant Joint Venture . " • EBITDARM Coverage for our Skilled Nursing / Transitional Care and Specialty Hospitals and Other portfolios were 1.99x and 3.91x , respectively . Together , our Aggregate Acute / Post Acute and Other facilities reported EBITDARM Coverage of 2.27x , which represents an increase of 0.36x over the second quarter of 2020 and an increase of 0.02x over the first quarter of 2021. This is notable since the current trailing twelve - month reporting period is the first that does not contain pre - pandemic performance and these asset classes combined represent 78.7 % of our total cash NOI . See further discussion on EBITDARM Coverage trends under " Business Update . " • From the beginning of the COVID - 19 pandemic through July 2021 , we have collected 99.8 % of our forecasted 1